Solna
Sweden
8
2025-02-06
5
2021-06-08
These are the the leading inventors for applications assigned to ASARINA PHARMA AB:
ASARINA PHARMA AB based in Solna, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Injectable Suspensions
#2 | 2023-04-20PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-5-ALPHA-PREGNAN-20-ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES
#3 | 2021-04-08Injectable Suspensions
#4 | 2019-12-19 ✅ Patent 11,026,953 granted on 2021-06-083-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor
#5 | 2019-11-28 ✅ Patent 11,026,954 granted on 2021-06-083-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment
#6 | 2019-11-21 ✅ Patent 10,933,014 granted on 2021-03-02Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof
#7 | 2017-09-14 ✅ Patent 11,534,446 granted on 2022-12-27Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
#8 | 2015-06-18 ✅ Patent 9,687,496 granted on 2017-06-27Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
Also check out ASARINA PHARMA AB's (Solna, Sweden) applicant profile with 5 patent applications submitted.
126507 ⎘